A judge has scolded lawyers for a former rugby player and the Australian Rugby League Commission for taking nearly three years to come to an agreement on discovery, calling the delay a “disgrace” and ordering the parties to agree to a hearing timetable by April.
Biogen said Thursday it will pull its multiple sclerosis drug Zinbryta in Australia, nearly two weeks after the biotech company issued a worldwide withdrawal of the drug following reports of encephalitus in Europe.
As Shine Lawyers awaits judgment in a marathon class action against Johnson & Johnson over its pelvic mesh implants, a separate class action by the firm kicked into gear Wednesday when a judge gave the ok to serve court papers on US-based American Medical Systems.
The class actions against car companies over defective Takata airbags are expected to dramatically grow after the first-of-its-kind mandatory recall announced by the government Wednesday.
The High Court of Australia will tackle the question of whether injured plaintiffs in tort cases are entitled to damages for the future loss of superannuation and the age pension.
A judge has rejected Amaca’s bid for indemnity costs in a case over contributions to an asbestos class action settlement, but he did not rule on the company’s novel argument that a settlement resulting from mediation could count as the outcome of litigation in awarding costs.
Toyota has become the first car manufacturer to be hit with a class action in Australia over faulty Takata airbags, Quinn Emanuel said Monday, and six other automakers are next.